Adcomm Cautions on Social, Emotional Risks Associated With Multi-Cancer Screening

Despite overall enthusiasm for the use of multi-cancer diagnostic (MCD) tests, several members of the Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee raised concerns about the social and emotional risks the technology might carry.
Source: Drug Industry Daily